Washington, DC - Marc Samuels, CEO of HillCo HEALTH, a reimbursement consulting and strategic business advisory firm to the healthcare industry, will moderate a panel at CBI's 6th Annual Obesity Diabetes Drug Development Summit, July 20-21, 2010, Arlington, Virginia. The panel includes representatives of payer, physician, manufacturer and public policy interests in the diabetes and obesity segment. The purpose of the panel is to detail an environmental landscape of obesity products by public and private payers, discuss opportunities to strengthen opportunities with government and the private sector in this segment, and strategies to gain Medicare coverage for drugs and biologics for this segment where currently no coverage exists.
HillCo HEALTH has significant experience in the diabetes and obesity segment of the pharmaceutical space. Its principals have consulted or been members of product teams for companies that developed and marketed the gastric sleeve and gastric bypass, and the lap band, as well as both over-the-counter and brand prescription medicines including Allergan, Amylin, Merck, Pfizer, Roche and Sanofi. Each principal has served in the industry, in state and federal government including the Centers for Medicare and Medicaid Services (CMS) or state Medicaid, in commercial managed care or physician organizations, including the American Medical Association.
www.hillcohealth.com
